2020
DOI: 10.1016/j.ijbiomac.2020.02.217
|View full text |Cite
|
Sign up to set email alerts
|

Interfacing DNA with nanoparticles: Surface science and its applications in biosensing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
27
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(29 citation statements)
references
References 176 publications
2
27
0
Order By: Relevance
“…Additionally, the detection performance and safety of MOF-based biosensing need to be further verified in vivo due to the complex in vivo environment, and the long-term biological toxicity of metal ion in MOF need to be further evaluated in vivo ( Chen et al, 2019 ), some biocompatible metal ions, such as Fe 2+ /Fe 3+ , Ni 3+ , Zr 4+ , Mn 2+ , Mg 2+ , Ca 2+ , Zn 2+ , or biomaterials, such as liposomal ( Dunne et al, 2019 ), bioconjugates ( Malfanti et al, 2019 ), and green synthetic routes should also be considered. The functional modification of MOFs with target ligands, such as aptamers ( Cai et al, 2018 ; He et al 2020a , 2020b ; Liu et al 2014a , 2015 ; Xiong et al, 2019 ) would endow the MOFs with more functionalities, with detection performances even better than the biosensor platforms based on graphene oxide ( Du et al, 2020 ; Liu et al, 2014b ).…”
Section: Discussion and Prospectivementioning
confidence: 99%
“…Additionally, the detection performance and safety of MOF-based biosensing need to be further verified in vivo due to the complex in vivo environment, and the long-term biological toxicity of metal ion in MOF need to be further evaluated in vivo ( Chen et al, 2019 ), some biocompatible metal ions, such as Fe 2+ /Fe 3+ , Ni 3+ , Zr 4+ , Mn 2+ , Mg 2+ , Ca 2+ , Zn 2+ , or biomaterials, such as liposomal ( Dunne et al, 2019 ), bioconjugates ( Malfanti et al, 2019 ), and green synthetic routes should also be considered. The functional modification of MOFs with target ligands, such as aptamers ( Cai et al, 2018 ; He et al 2020a , 2020b ; Liu et al 2014a , 2015 ; Xiong et al, 2019 ) would endow the MOFs with more functionalities, with detection performances even better than the biosensor platforms based on graphene oxide ( Du et al, 2020 ; Liu et al, 2014b ).…”
Section: Discussion and Prospectivementioning
confidence: 99%
“…2D materials, nanoparticles). [27][28][29] Here, we are reviewing all types of dimensional interfaces of the nanomaterials, except macroscopic interfaces (e.g. surfaceassemblies on microbeads and macro electrode surfaces), [30][31][32] with key developments in the biosensing applications of the DNA-materials interfaces since 2015.…”
Section: Introductionmentioning
confidence: 99%
“…Because of their substantially small size, nanomaterials may be formed by hundreds of millions of atoms [5]. Due to the high surface-to-volume ratio, the use of this type of carriers allows to deliver of small therapeutic biomolecules like DNA [6], RNA [7], proteins [8], drugs [9], and other molecules to a specific tumoral site. Nanoparticles can be functionalized with some recognition molecules, such as antibodies [10] or aptamers [11], that can target the nanoparticle into the cancerous cells, avoiding the endocytosis into healthy cells.…”
Section: Introductionmentioning
confidence: 99%